ASP.TO
Acerus Pharmaceuticals Corporation
Price:  
0.36 
CAD
Volume:  
201,039.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ASP.TO EV/EBITDA

-7648.7%
Upside

As of 2025-07-06, the EV/EBITDA ratio of Acerus Pharmaceuticals Corporation (ASP.TO) is -2.38. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ASP.TO's latest enterprise value is 61.42 mil CAD. ASP.TO's TTM EBITDA according to its financial statements is -25.78 mil CAD. Dividing these 2 quantities gives us the above ASP.TO EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 3.4x - 4.5x 4.3x
Forward P/E multiples 3.4x - 5.2x 4.3x
Fair Price (23.26) - (28.09) (27.18)
Upside -6561.7% - -7901.5% -7648.7%
0.36 CAD
Stock Price
(27.18) CAD
Fair Price

ASP.TO EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA